I now have rich content from multiple textbooks. Let me compile a thorough, well-organized study guide covering all the midterm topics.
Biochemistry Midterm Study Guide
Covering: General Digestion | Lipid Digestion, Absorption, Mobilization, Metabolic Fate & Degradation | Protein Digestion, Absorption & Degradation
PART 1 - General Principles of Digestion
The Chemistry: Hydrolysis
All three major macronutrients - carbohydrates, fats, and proteins - are digested by the same fundamental chemical process: hydrolysis. During condensation (polymerization), water molecules are removed to form covalent bonds between monomers. Digestion reverses this: enzymes return H⁺ and OH⁻ from water molecules to break those bonds back into absorbable monomers.
| Macronutrient | Bond Hydrolyzed | Products |
|---|
| Carbohydrates | Glycosidic bonds | Monosaccharides |
| Fats (triglycerides) | Ester bonds | Fatty acids + glycerol |
| Proteins | Peptide bonds | Amino acids |
All digestive enzymes are themselves proteins.
- Guyton and Hall Textbook of Medical Physiology
Overview: Sites of Digestion
| Region | Key Secretions | What Gets Digested |
|---|
| Mouth | Salivary amylase (ptyalin) | Starch → maltose/dextrins |
| Stomach | Pepsin (from pepsinogen), gastric lipase, HCl | Proteins begin; some fat |
| Small intestine (duodenum/jejunum) | Pancreatic enzymes, bile from liver | Major site for all 3 macronutrients |
| Intestinal brush border | Disaccharidases, aminopeptidases | Final cleavage |
PART 2 - Lipid Digestion and Absorption
2A. Digestion of Lipids
Dietary lipid is primarily triglycerides (triacylglycerols) - three fatty acids esterified to glycerol. Additional dietary lipids include phospholipids, cholesterol esters, and fat-soluble vitamins.
Step-by-step digestion:
-
Mouth/stomach - Lingual and gastric lipases initiate hydrolysis, especially important in neonates (pancreatic lipase is only ~10% of adult levels at term). Gastric lipase can be detected as early as 10-13 weeks of gestation.
-
Duodenum (main site):
- Acidic chyme from the stomach must be neutralized by pancreatic HCO₃⁻ to reach pH ~6, the optimum for pancreatic lipase
- Pancreatic lipase (with its cofactor colipase) cleaves triglycerides into 2-monoglycerides + 2 free fatty acids
- Cholesterol ester hydrolase cleaves cholesterol esters
- Phospholipase A₂ cleaves phospholipids
-
Emulsification: Bile salts (secreted by the liver, stored in the gallbladder) emulsify fat droplets, dramatically increasing the surface area for lipase action
-
Micelle formation: Products of lipid digestion (monoglycerides, fatty acids, lysophospholipids, cholesterol) are solubilized into mixed micelles - bile salt aggregates that carry the hydrophobic products to the brush border for absorption
- Costanzo Physiology 7th Edition
2B. Absorption of Lipids
- Lipid products diffuse out of micelles and passively diffuse across the enterocyte brush border membrane (they are lipid-soluble)
- Inside enterocytes, fatty acids + monoglycerides are re-esterified to form triglycerides
- Triglycerides + cholesterol + phospholipids are packaged with apolipoprotein B-48 into chylomicrons
- Chylomicrons exit the enterocyte by exocytosis and enter the lymphatics (lacteals), not the portal blood
- Short-chain and medium-chain fatty acids (< ~12 carbons) are water-soluble enough to enter the portal blood directly
2C. Mobilization of Lipids (from Adipose Tissue)
Triacylglycerol storage and release:
| Condition | Hormone | Effect on Adipose |
|---|
| Fed state | Insulin | Activates lipoprotein lipase; promotes fat storage |
| Fasting/stress | Glucagon, epinephrine, cortisol | Activate hormone-sensitive lipase (HSL) |
- Hormone-sensitive lipase (HSL) is activated by cAMP-dependent phosphorylation (via glucagon/epinephrine signaling)
- HSL hydrolyzes stored triglycerides → free fatty acids (FFAs) + glycerol
- FFAs are released into the bloodstream bound to albumin and transported to tissues (muscle, heart, liver)
- Glycerol travels to the liver for gluconeogenesis
2D. Metabolic Fate of Fatty Acids - Beta-Oxidation
Entry into mitochondria:
Fatty acids cannot cross the inner mitochondrial membrane freely. They are activated to fatty acyl-CoA (consuming 2 ATP equivalents), then the acyl group is transferred to carnitine (by carnitine acyltransferase I on the outer membrane). The acylcarnitine crosses via a translocase, and carnitine is released on the inner side by carnitine acyltransferase II.
Key regulation point: Malonyl-CoA (the first intermediate in fatty acid synthesis) inhibits carnitine acyltransferase I - this prevents simultaneous synthesis and oxidation of fatty acids.
Beta-oxidation cycle (in the mitochondrial matrix):
Each cycle removes 2 carbons as acetyl-CoA and generates 1 FADH₂ + 1 NADH:
- Oxidation (FAD → FADH₂): acyl-CoA dehydrogenase
- Hydration: enoyl-CoA hydratase
- Oxidation (NAD⁺ → NADH): 3-hydroxyacyl-CoA dehydrogenase
- Thiolysis: thiolase cleaves off acetyl-CoA → shorter acyl-CoA returns to step 1
Energy yield from stearic acid (18C):
- 9 acetyl-CoA molecules → enter TCA cycle
- 8 cycles of beta-oxidation → 8 FADH₂ + 8 NADH
- Total ATP from 1 stearic acid ≈ 146 net ATP (after subtracting 2 for activation)
- Guyton and Hall Textbook of Medical Physiology
Acetyl-CoA then:
- Enters the TCA (citric acid) cycle → CO₂ + H₂O + ATP
- Is converted to ketone bodies when oxaloacetate is limiting (e.g., fasting, diabetes)
2E. Ketone Body Formation (Ketogenesis)
- Occurs primarily in the liver during prolonged fasting, starvation, or uncontrolled diabetes
- When oxaloacetate is diverted to gluconeogenesis, excess acetyl-CoA cannot enter the TCA cycle
- Two acetyl-CoA condense → acetoacetyl-CoA → acetoacetic acid (a ketone body)
- Acetoacetate is reduced to β-hydroxybutyrate (most abundant in blood) or spontaneously decarboxylated to acetone (expired in breath)
- Peripheral tissues (brain during starvation, muscle, heart) take up ketone bodies and convert them back to acetyl-CoA for energy
2F. Abnormalities of Lipid Digestion/Absorption
Any disruption in the following sequence causes steatorrhea (fat in the feces):
| Step | Disorder | Mechanism |
|---|
| Pancreatic enzyme secretion | Chronic pancreatitis, cystic fibrosis | Insufficient lipase/colipase; triglycerides undigested |
| Duodenal pH | Zollinger-Ellison syndrome, pancreatitis | Excess H⁺ inactivates lipase (optimum pH ~6) |
| Bile salt availability | Ileal resection, cholestasis, liver disease | Micelle formation fails; products not solubilized |
| Chylomicron formation | Abetalipoproteinemia | Defective apoB-48; fat accumulates in enterocytes |
| Lymphatic transport | Intestinal lymphangiectasia | Chylomicrons cannot enter lymphatics |
Costanzo Physiology 7th Edition
PART 3 - Protein Digestion, Absorption, and Degradation
3A. Protein Digestion
Proteins are digested by proteases (peptidases) - most are secreted as inactive zymogens to prevent autodigestion.
Stomach:
- Pepsinogen → pepsin (activated by low pH of HCl; autocatalytic)
- Pepsin cleaves proteins → smaller polypeptides (endopeptidase; prefers aromatic residues)
Pancreas (secreted into duodenum):
| Zymogen | Active Enzyme | Type | Specificity |
|---|
| Trypsinogen | Trypsin | Endopeptidase | Cleaves after Arg, Lys |
| Chymotrypsinogen | Chymotrypsin | Endopeptidase | Cleaves after Phe, Tyr, Trp |
| Proelastase | Elastase | Endopeptidase | Cleaves after Ala, Gly, Ser |
| Procarboxypeptidase A/B | Carboxypeptidases A/B | Exopeptidase | Removes C-terminal residues |
- Enteropeptidase (enterokinase) on the duodenal brush border activates trypsinogen → trypsin; trypsin then activates all other zymogens (cascade)
- Note: elastase is also found in neutrophils and is counteracted by α-1-antitrypsin in the lung
Intestinal brush border and cytoplasm:
- Aminopeptidases on the brush border cleave N-terminal residues from oligopeptides
- Dipeptidases and tripeptidases within enterocytes complete digestion to free amino acids
- Basic Medical Biochemistry - A Clinical Approach, 6e
3B. Amino Acid Absorption
- Free amino acids and small peptides (di/tripeptides) are absorbed across the intestinal brush border
- Multiple transport systems exist - some are Na⁺-linked secondary active transporters (require energy, allow uptake against concentration gradient); others are facilitative transporters
- Di/tripeptides enter via PepT1 (H⁺-coupled) and are hydrolyzed to amino acids inside the cell
- Amino acids exit the basolateral side into portal blood
Clinically important transport defects:
- Cystinuria: Defective transport of cystine, arginine, and lysine in the kidney tubule (and intestine) → cystine kidney stones (cystine is poorly soluble)
- Hartnup disease: Defective neutral amino acid transport → tryptophan deficiency → pellagra-like rash (tryptophan is precursor for niacin)
- Basic Medical Biochemistry - A Clinical Approach, 6e
3C. Intracellular Protein Degradation (Turnover)
Proteins are continuously synthesized and degraded (protein turnover). Two major pathways:
1. Lysosomal pathway:
- Extracellular proteins, membrane proteins, and long-lived intracellular proteins
- Degraded by cathepsins (proteases inside lysosomes)
- Important in autophagy
2. Ubiquitin-Proteasome pathway:
- Misfolded, damaged, or short-lived proteins targeted for degradation
- Ubiquitin (a small 76-aa protein) is covalently attached to the target protein via isopeptide bonds (requires E1, E2, E3 ligases + ATP)
- Polyubiquitinated protein is recognized by the 26S proteasome
- The proteasome unfolds and degrades the protein in an ATP-dependent manner
- Amino acids released can be reused for new protein synthesis or catabolized for energy
- Basic Medical Biochemistry - A Clinical Approach, 6e
3D. Amino Acid Catabolism
When amino acids are degraded for energy:
-
Transamination: The amino group is transferred to α-ketoglutarate → glutamate (catalyzed by aminotransferases using pyridoxal phosphate / vitamin B₆)
-
Oxidative deamination: Glutamate → α-ketoglutarate + NH₄⁺ (catalyzed by glutamate dehydrogenase in the mitochondria)
-
Urea cycle (liver): NH₄⁺ is toxic - converted to urea for excretion
- Key enzymes: carbamoyl phosphate synthetase I (mitochondria), OTC, argininosuccinate synthetase, argininosuccinate lyase, arginase
- Urea is excreted in urine
-
Carbon skeletons enter the TCA cycle or other pathways:
- Glucogenic amino acids → pyruvate or TCA intermediates → glucose (gluconeogenesis)
- Ketogenic amino acids → acetyl-CoA or acetoacetate → ketone bodies or fatty acids
- Some are both (e.g., phenylalanine, tyrosine, isoleucine)
PART 4 - High-Yield Summary Tables
Key Enzymes - Lipid Digestion
| Enzyme | Source | Substrate | Product |
|---|
| Lingual/gastric lipase | Serous glands, gastric mucosa | Triglycerides | DAG + fatty acid |
| Pancreatic lipase | Pancreas (requires colipase) | Triglycerides | 2-MAG + 2 FFAs |
| Cholesterol ester hydrolase | Pancreas | Cholesterol esters | Cholesterol + FA |
| Phospholipase A₂ | Pancreas | Phospholipids | Lysophospholipid + FA |
Key Enzymes - Protein Digestion
| Enzyme | Zymogen | Activated By | Type |
|---|
| Pepsin | Pepsinogen | HCl (autocatalytic) | Endopeptidase |
| Trypsin | Trypsinogen | Enteropeptidase | Endopeptidase |
| Chymotrypsin | Chymotrypsinogen | Trypsin | Endopeptidase |
| Elastase | Proelastase | Trypsin | Endopeptidase |
| Carboxypeptidase | Procarboxypeptidase | Trypsin | Exopeptidase |
Lipid Transport Forms in Blood
| Particle | Origin | Carries | Destination |
|---|
| Chylomicron | Intestine | Dietary TG | Tissues (via LPL) |
| VLDL | Liver | Endogenous TG | Tissues (via LPL) |
| IDL | VLDL remnant | TG + cholesterol | Liver or → LDL |
| LDL | IDL | Cholesterol | All cells |
| HDL | Liver/intestine | Cholesterol | Liver (reverse transport) |
PART 5 - Clinical Correlations (Exam Favorites)
| Condition | Defect | Biochemical Consequence |
|---|
| Cystic fibrosis | CFTR mutation → thick mucus blocks pancreatic ducts | Malabsorption of fat + protein; steatorrhea; low albumin |
| Zollinger-Ellison syndrome | Gastrinoma → excess H⁺ secretion | Inactivates lipase → fat malabsorption + diarrhea |
| Cystinuria | Defective renal/intestinal amino acid transporter | Kidney stones (cystine); not nutritionally deficient |
| α-1-antitrypsin deficiency | Mutant inhibitor; elastase unchecked | Emphysema; also liver disease (protein misfolding) |
| Kwashiorkor | Protein deficiency | Muscle wasting, hypoalbuminemia, edema, impaired enzyme synthesis |
| Abetalipoproteinemia | No apoB-48 → no chylomicrons | Fat-soluble vitamin deficiency, steatorrhea, acanthocytosis |
| Diabetic ketoacidosis | Insulin deficiency → uncontrolled lipolysis + ketogenesis | Excess acetyl-CoA → ketone bodies → metabolic acidosis |
Sources:
- Basic Medical Biochemistry: A Clinical Approach, 6e (Lippincott)
- Guyton and Hall Textbook of Medical Physiology
- Costanzo Physiology, 7th Edition
- Yamada's Textbook of Gastroenterology, 7th Edition